Leo Cancer Care Launches Upright Radiotherapy Platform
The new platform offers flexible treatment options for cancer patients.
Leo Cancer Care has transitioned its upright radiotherapy platform from concept to clinical use, marking a significant advancement in radiation oncology. The Upright Platform is designed to be beam-agnostic, allowing integration with various particle and photon beam technologies, which provides healthcare networks with increased flexibility in treatment options.
The first clinical treatment using the Marie® upright patient positioning system occurred in June 2026. This system, developed in collaboration with Mevion Medical Systems and powered by RayStation® from RaySearch Laboratories, enables patients to receive radiotherapy while standing, potentially improving their treatment experience.
In addition to its initial offering, Leo Cancer Care is developing a dedicated fixed-beam photon platform, which is pending regulatory clearance. This new platform aims to further enhance patient choice and access to high-quality cancer care by integrating upright positioning and imaging.
The upright radiotherapy method involves fixing the radiation beam while the patient is positioned upright and rotated to various angles. This setup allows for personalized treatment planning and enhances the accuracy of treatment delivery, as the patient is imaged in the same position they are treated. Such an approach may be particularly beneficial for patients who experience discomfort lying flat due to various health issues.
International research suggests that upright positioning can lead to improved anatomical consistency and reduced organ motion during treatment, which could enhance treatment outcomes. As more upright systems are adopted in clinical settings, the potential benefits will continue to be explored.
Stephen Towe, Co-Founder and CEO of Leo Cancer Care, stated, "The first clinical treatment using our technology proved that upright radiotherapy is no longer simply an idea for the future. It is now a clinical reality." This development aims to simplify the treatment process by integrating imaging, planning, positioning, and delivery into a cohesive workflow.
The announcement of this technology was made at the 2026 Annual Meeting of the American Society for Radiation Oncology in Boston, where Leo Cancer Care plans to discuss its clinical progress and future objectives.
This is an independent summary of a press release originally distributed via PR Newswire. GAX Online was not paid for this coverage.
Have news to announce?
Get your launch, funding round, or partnership covered on GAX Online, in front of tech buyers and the AI answer engines that cite us.
Submit your press release →